Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure:<i>post hoc</i>analysis of a randomised clinical trial
Luca S. Menga, Domenico Luca Grieco, Tommaso Rosà, Melania Cesarano, Luca Delle Cese, Cecilia Berardi, Gabriele Pintaudi, Eloisa Sofia Tanzarella, Salvatore Lucio Cutuli, Gennaro De Pascale, Salvatore Maurizio Maggiore, Massimo Antonelli
Abstract
In non-COVID-19 acute hypoxaemic respiratory failure, the entity of dyspnoea has been associated with severity of hypoxaemia, and represents a factor predicting noninvasive ventilation (NIV) failure, the need for endotracheal intubation and mortality [1]. In #COVID19 patients, presence of moderate-to-severe dyspnoea is a marker of disease severity correlated to clinical outcomes <https://bit.ly/3Bp2G1b> We are grateful to all intensive care unit physicians, residents, nurses and personnel from the participating centres, whose sacrifice, efforts, devotion to patients and passion have made possible this timely report. Members of the COVID-ICU Gemelli study group: Gian Marco Anzellotti, Giuseppe Bello, Maria M. Bitondo, Maria Grazia Bocci, Filippo Bongiovanni, Simone Carelli, Laura Cascarano, Giorgio Conti, Paolo De Santis, Antonio M. Dell'Anna, Mariangela Di Muro, Miriana Durante, Giulia Falò, Nicoletta Filetici, Veronica Gennenzi, Antonio Gullì, Gianmarco Lombardi, Alessio Maccaglia, Riccardo Maviglia, Alessandro Mele, Giovanna Mercurio, Teresa Michi, Tony C. Morena, Luca Montini, Jonathan Montomoli, Martina Murdolo, Daniele Natalini, Mariano Alberto Pennisi, Edoardo Piervincenzi, Stefania Postorino, Francesca Pozzana, Martina Savino, Roberta Scarascia, Angela Scavone, Donatella Settanni, Serena Silva, Savino Spadaro, V. Marco Ranieri, Tommaso Tonetti, Joel Vargas, Matteo Velardo, Carlo Alberto Volta and Carmelina Zaccone.